Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients.
Saved in:
| Title: | Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients. |
|---|---|
| Authors: | Doi, T1, Takiuchi, H2, Ohtsu, A1, Fuse, N1, Goto, M2, Yoshida, M2, Dote, N3, Kuze, Y3, Jinno, F3, Fujimoto, M4, Takubo, T5, Nakayama, N5, Tsutsumi, R6 |
| Source: | British Journal of Cancer. 2/14/2012, Vol. 106 Issue 4, p666-672. 7p. 4 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/bjc.2011.590 |
